Contract Pharmaceuticals Limited Canada: Drug Recall

Recall #D-0364-2024 · 02/20/2024

Class III: Low Risk

Recall Details

Recall Number: D-0364-2024
Classification: Class III
Product Type: Drug
Recalling Firm: Contract Pharmaceuticals Limited Canada
Status: Ongoing
Date Initiated: 02/20/2024
Location: Mississauga, Canada
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 45,875 bottles

Reason for Recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Product Description

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

Distribution Pattern

Nationwide in the U.S. and Puerto Rico

Other Recalls by Contract Pharmaceuticals Limited Canada

Class III: Low Risk 02/20/2024

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Class III: Low Risk 08/23/2023

Defective Container: slow leakage under the cap

View all recalls by Contract Pharmaceuticals Limited Canada →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.